Free Trial

Cardlytics (CDLX) Stock Price, News & Analysis

+0.28 (+3.16%)
(As of 07/23/2024 ET)
Today's Range
50-Day Range
52-Week Range
740,991 shs
Average Volume
617,839 shs
Market Capitalization
$446.34 million
P/E Ratio
Dividend Yield
Price Target

Cardlytics MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.86 Rating Score
38.4% Upside
$12.67 Price Target
Short Interest
15.78% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
Insider Trading
Acquiring Shares
$2 M Bought Last Quarter
Proj. Earnings Growth
From ($1.80) to ($1.30) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.00 out of 5 stars

Business Services Sector

60th out of 304 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

13th out of 58 stocks

CDLX stock logo

About Cardlytics Stock (NASDAQ:CDLX)

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.

CDLX Stock Price History

CDLX Stock News Headlines

First a 1,129% win in 2 days... .Now this???
Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...
5 Best Marketing Stocks to Buy
First a 1,129% win in 2 days... .Now this???
Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...
Why Is Cardlytics (CDLX) Stock Down 29% Today?
Cardlytics: Q1 Earnings Snapshot
CDLX Jul 2024 9.000 put (CDLX240719P00009000)
Cardlytics executive sells over $3.5k in stock
See More Headlines
Receive CDLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardlytics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Computer programming, data processing, & other computer related
Computer Software
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$312.48 million
Cash Flow
$1.36 per share
Book Value
$3.43 per share


Free Float
Market Cap
$446.36 million

Social Links

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Karim Temsamani (Age 50)
    CEO & Director
    Comp: $917.94k
  • Ms. Alexis DeSieno (Age 40)
    Chief Financial Officer
    Comp: $565.84k
  • Mr. Amit Gupta (Age 51)
    COO & GM of Bridg
    Comp: $732.48k
  • Mr. Nick Lynton (Age 41)
    Chief Legal & Privacy Officer and Secretary
    Comp: $577.42k
  • Mr. Peter Chan
    Chief Technology Officer
  • Mr. Peter Davies
    Head of Sales Strategy & Operations
  • Ms. Carson Napps
    Head of People
  • Mr. Jose Singer
    Chief Product Officer
  • Ms. Evelyne Forester
    Chief Business Officer

CDLX Stock Analysis - Frequently Asked Questions

How have CDLX shares performed this year?

Cardlytics' stock was trading at $9.21 on January 1st, 2024. Since then, CDLX shares have decreased by 0.7% and is now trading at $9.15.
View the best growth stocks for 2024 here

How were Cardlytics' earnings last quarter?

Cardlytics, Inc. (NASDAQ:CDLX) issued its quarterly earnings results on Wednesday, May, 8th. The company reported ($0.35) earnings per share (EPS) for the quarter. The firm earned $67.61 million during the quarter. Cardlytics had a negative trailing twelve-month return on equity of 25.36% and a negative net margin of 55.23%.

What is Lynne Laube's approval rating as Cardlytics' CEO?

26 employees have rated Cardlytics Chief Executive Officer Lynne Laube on Lynne Laube has an approval rating of 86% among the company's employees. 61.0% of employees surveyed would recommend working at Cardlytics to a friend.

Does Cardlytics have any subsidiaries?

Cardlytics subsidiaries include Bridg, DOSH, Cardlytics Services India Private Limited, and Cardlytics UK Limited.

When did Cardlytics IPO?

Cardlytics (CDLX) raised $76 million in an initial public offering (IPO) on Friday, February 9th 2018. The company issued 5,400,000 shares at $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

Who are Cardlytics' major shareholders?

Cardlytics' top institutional shareholders include Shikiar Asset Management Inc. (0.06%) and Canton Hathaway LLC (0.01%). Insiders that own company stock include Clifford Sosin, Karim Saad Temsamani, Lynne Marie Laube, Scott D Grimes, Amit Gupta, Nicholas Hollmeyer Lynton, Andrew Christiansen, John V Balen, Kirk Somers and Alexis Desieno.
View institutional ownership trends

How do I buy shares of Cardlytics?

Shares of CDLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardlytics investors own include NVIDIA (NVDA), Block (SQ), DocuSign (DOCU), Advanced Micro Devices (AMD), Caterpillar (CAT), Walt Disney (DIS) and Alibaba Group (BABA).

This page (NASDAQ:CDLX) was last updated on 7/24/2024 by Staff

From Our Partners